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Abstract
In this study we have examined the pathway by which papillomaviruses infect cells, using bovine papillomavirus (BPV) virions and
mouse C127 cells as the model system. By confocal microscopy, the entry of BPV virions, BPV virus-like particles (VLPs), and HPV16
VLPs were very similar. In dually exposed cells, HPV-16 VLPs and BPV virions colocalized intracellularly. BPV VLPs colocalized with
AP-2, a clathrin adapter molecular and a marker of the clathrin-dependent endocytic pathway; and also with transferrin receptor, a marker
of early endosomes; and Lamp-2, a marker of late endosomes and lysosomes. BPV infection was detected within 12 h of virion cell-surface
binding, as measured by an RT-PCR assay. Infection was prevented by several pharmacologic inhibitors, including chlorpromazine, which
blocks clathrin-dependent endocytosis and the lysosomotropic agent, bafilomycin A. By contrast, two inhibitors of caveolae-dependent
uptake, filipin and nystatin, did not prevent BPV infection. We conclude that papillomaviruses infect cells via clathrin-dependent
receptor-mediated endocytosis. Surprisingly, the kinetics of internalization were unusually slow for this mechanism, with the t1/2 of entry
of BPV-1 being approximately 4 h versus 5–15 min for a typical ligand.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Papillomaviruses (PVs) are nonenveloped, icosahedral
DNA viruses that persistently infect stratified squamous
epithelia from a wide spectrum of animal species. These
viruses are implicated etiologically in a number of epithelial
lesions, most notably human cervical carcinoma (Zur
Hausen, 1991).
The completion of the infectious pathway of PVs is
difficult to achieve in vitro, as the late events in the cycle are
tied to keratinocyte differentiation (Taichman et al., 1984).
This experimental difficulty has resulted in limited experi-
mental analysis of the pathway by which PVs infect cells,
with no systematic analysis of the trafficking pathways for
PV virions. However, the early events in viral infectivity
can be studied with PV virions and appropriate monolayer
cultures. Aspects of this process can also be examined with
PV virus-like particles (VLPs), providing that VLPs and
virions can be shown to interact similarly with the cell.
Previous analyses of the PV entry pathway have demon-
strated a dependence upon an intact actin cytoskeleton.
However, electron microscopic analysis has led to conflict-
ing results as to whether PVs enter cells via coated or
uncoated vesicles (Volpers et al., 1995; Zhou et al., 1995).
Following binding to cell-surface receptors, viruses are
internalized into the intracellular milieu via one of several
possible pathways. Nonenveloped viruses generally enter
through clathrin-coated endocytic vesicles or the clathrin
independent caveolae system, which produces uncoated
vesicles. In the former system, a carrier vesicle intermediate
is used to deliver virions into endosomes and lysosomes
(reviewed in Schmid, 1997). This vesicular microenviron-
ment may facilitate viral infection, possibly through a weak-
ening of the previously resistant capsid as occurs for mem-
bers of the reovirus family (Dryden et al., 1993; Ludert et
al., 1987; Virgin et al., 1994) or through a pH-dependent
release of virions into the cytoplasm as described for ad-
enoviruses (Fujimoto et al., 2000; Greber et al., 1993). In
the other system, virions entering the cell via caveolar
endocytosis are transported into the smooth ER through a
pathway that is independent of endosomes and lysosomes
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(Anderson et al., 1992; Pelkmans et al., 2001). The distinc-
tion between these two pathways can be achieved through
analysis of the pattern of biochemical inhibition of ligand
uptake and by colocalization of input virus with defined
components of the cellular trafficking machinery.
It is difficult to predict a priori which pathway is utilized
by PVs. For example, among polyomaviruses, whose capsid
structure is similar to that of PVs, some members, such as
JC, use the clathrin pathway (Pho et al., 2000), while others,
such as SV40, enter cells via caveolae (Anderson et al.,
1992; Chen and Norkin, 1999; Stang et al., 1997). To
identify the pathway experimentally, we have here exam-
ined the entry of bovine papillomavirus type 1 (BPV) into
C127 cells, a standard virus-cell system for the analysis of
PV infection, which results in stable nonproductive cellular
transformation (Dvoretzky et al., 1980; Law et al., 1981;
Watts et al., 1984). We have combined microscopic evalu-
ation of cell-associated virus with an RT-PCR assay that
detects the expression of early spliced BPV-1 mRNA. By
using these assays in conjunction with a battery of com-
pounds that inhibit various trafficking pathways, we have
determined that PVs enter cells via clathrin-dependent re-
ceptor-mediated endocytosis.
Results
VLPs and virions utilize the same intracellular pathway
It has recently been suggested that virions (or DNA-
containing VLPs) and empty VLPs may differ in their
stability and their sensitivity to protease digestion, as the
result of additional disulfide bond formation in capsid pro-
teins following DNA packaging (Fligge et al., 2001). It was
hypothesized that this increased stability in DNA-contain-
ing particles may result in differential association with cel-
lular receptors. This is a critical issue, as most studies of PV
adsorption and penetration have utilized VLPs rather than
virions.
To compare our virion and VLP preparations for possible
differences in their rate of internalization or subcellular
localization, we examined BPV virions, purified from bo-
vine warts, and BPV VLPs in parallel microscopy time-
course experiments. No obvious differences were detected
between BPV virions and BPV VLPs (data not shown,
though comparable to Fig. 2B). It was not feasible to per-
form the cytometric analysis, which requires larger amounts
of particles, with the virions due to limited availability of
this material.
Therefore, to address this question even more strin-
gently, we simultaneously incubated cells with BPV virions
and HPV-16 VLPs. Although evolutionarily divergent, it is
likely that these viruses share a common receptor as HPV
16 VLPs can compete with BPV for cell-surface binding
(Roden et al., 1994a). Since there are monoclonal anti-
capsid antibodies that specifically recognize BPV or HPV16
L1 epitopes, double staining with these antibodies enabled
us to compare the localization of virions and VLPs within
the same cells. Using this approach, we found that the
pattern of staining overlapped substantially (Fig. 1 shows
double staining against HPV-16 L1 and BPV-1 L1 at the 4
and 8 h time points), although some vesicles contained only
one particle type. The use of monoclonal antibodies that
exhibit different profiles of reactivity (Booy et al., 1998;
Roden et al., 1994b; Slupetzky et al., 2001) could explain
the apparent lack of absolute colocalization.
We conclude that major differences do not exist in the
uptake pathways of our preparations of VLPs and virions
due to the evidence that they share a common cell-surface
receptor and colocalize in intracellular compartments.
Therefore, examining VLP trafficking and localization
should give an adequate representation of the authentic viral
pathway.
BPV-1 VLPs are slowly internalized
Before examining the post-binding events in detail, we
sought to determine the rate at which BPV is internalized.
As preparative amounts of VLPs are more readily available
than virions and, as we had previously established their
utility, we characterized this process with BPV VLPs.
To determine the t1/2 of VLP internalization, VLPs were
bound to the surface of C127 cells at 0°C and allowed to be
internalized at 37°C. At defined times cells were removed
and stained with monoclonal antibody 5B6, which recog-
nizes a conformational determinant on the BPV capsid. 5B6
reactivity was quantified by flow cytometric analysis. Trip-
licate stainings were averaged for each time point. The
standard error was below 3% for each series. The mean
channel fluorescence at the 0-min time point was designated
100%. There was an apparent lag in initiation of endocytosis
of VLPs, with no significant internalization occurring dur-
ing the initial 60 min (Fig. 2A). After this time, the loss of
cell-surface VLPs was linear, with approximately 50% of
the VLPs internalized by approximately 4 h. In parallel
incubations analyzed microscopically, capping of surface
VLPs was evident during the first hour of incubation at
37°C with significant cytoplasmic vesicles evident by 2 h at
37°C (Fig. 2B).
To rule out the possibility that some of the time-depen-
dent loss of 5B6 reactivity from the cell surface might have
resulted in part from VLPs that dissociated from the cell
surface, rather than from VLP internalization, cell superna-
tants from each time point were analyzed for the presence of
5B6-reactive material by ELISA. However, no VLPs were
found to be released from the cell surface after initiation of
internalization (data not shown), although the 5B6 ELISA
was sensitive enough to detect as little as 1% of the VLPs
bound to the cells. These results strongly suggest that the
time-dependent decrease in cell-surface 5B6 staining has
resulted primarily from the entry of VLPs into the cell.
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Colocalization with markers of endocytic uptake
To study the internalization pathway followed by BPV
VLPs, we first examined their possible colocalization with
established markers of endocytic pathways. The markers
studied included the following: AP-2, which is a clathrin
adaptor protein; transferrin receptor, which is a marker for
the early endosomal compartment; and Lamp-2, which is a
marker of late endosomes and lysosomes.
Cells were allowed to internalize VLPs for defined time
periods. They were then fixed and stained with the various
marker proteins and the 5B6 antibody against BPV L1
protein. After 2 h at 37°C, colocalization of BPV L1 and the
clathrin adaptor protein, AP-2 (Fig. 3,A–C), was clearly
evident. By 3 h of internalization colocalization of BPV L1
and transferrin receptor was readily apparent (Fig. 3D–F),
indicating further passage of the VLPs to the early endo-
cytic compartment. By contrast, no clear colocalization with
anti-Lamp-2 staining was evident with the anti-L1 antibody
5B6 at any time point (data not shown).
Many viruses escape the endocytic pathway prior to this
point. However, an alternate possibility was that the BPV
L1 VLPs might have been transported to the late endosomal
and lysosomal compartments, but that transit to these com-
partments might have been associated with a conforma-
tional change in L1 leading to the loss of reactivity to the
5B6 antibody. To evaluate this possibility, the fixed cells
were stained with another BPV L1 antibody, no. 9, which
recognizes a conformational epitope that is distinct from
that of 5B6. In contrast to the results obtained with 5B6,
antibody no. 9 did display strong localization within Lamp-
positive compartment (late endosomes and lysosomes) be-
ginning approximately 4 h after initiation of internalization
(Fig. 3G–I show the localization at 7 h). The staining of the
membrane-associated Lamp-2 protein appears to encircle
the anti-VLP staining, indicating their presence within these
vesicles. These positive results indicate BPV L1 protein that
has retained some of its conformational epitopes can be
found in late endosomes and/or lysosomes. The use of
antibodies raised against linear L1 epitopes yielded no fur-
ther information due to extensive background staining (data
not shown).
Biochemical inhibition of BPV-1 infection
The above results localizing the VLPs within AP-2-
postive vesicles and later vesicles of the endocytic compart-
ment are consistent with the particles having been internal-
ized via clathrin-coated pits. However, this conclusion
would seem to be at odds with the observed kinetics of PV
internalization, as most ligands that are endocytosed via the
clathrin-dependent pathway do so with a t1/2 of 5 to 15 min
(Goldenthal et al., 1988; Schmid et al., 1988), while the t1/2
of BPV-1 internalization was approximately 4 h (Fig. 2).
Therefore, to strengthen the conclusion that BPV internal-
ization is mediated via this pathway, we examined the
sensitivity of BPV infection to a variety of biochemical
inhibitors known to inhibit distinct cellular processes.
To identify successful virus entry and uncoating, we
measured the appearance of an early spliced mRNA in C127
cells after the addition of infectious BPV virions. We rea-
soned that this type of assay would be a sensitive and rapid
way to definitively monitor the completion of the early
events in viral entry and uncoating. BPV virions were added
to C127 cells; cells were harvested at set time points postin-
fection, and RNA was prepared. RT-PCR was performed
using primers across a splice site of the early genes E6^E7
of BPV, and as a control for mRNA integrity, across a
spliced junction in the cellular -actin gene. A second round
of PCR was run using primers internally nested to the first
set. The amplimers from this reaction were analyzed elec-
trophoretically. Fig. 4A shows that the specific RNA band
indicating transcription of the BPV-1 early gene was first
evident 12 h postinfection. The actin transcripts demon-
strate RNA integrity at all time points.
To determine the sensitivity of the assay, we added
decreasing amounts of virions to C127 cells and allowed the
infection to continue for 14 h. We found that a strong signal
was detectable down to 80 ng/106 cells; a weaker signal was
obvious at 32 ng/106 cells, and no signal was observed
below this input level (Fig. 4B). One microgram of virions
is equal to approximately 3  1010 particles, so the detect-
able limit of 32 ng/106 cells is equivalent to approximately
1000 virions per cell. Given the high particle-to-infectivity
ratio described for papillomavirus (Roden et al., 1996;
Smith et al., 1995), this is not a high m.o.i. In a focus
formation assay, a particle-to-infectivity ratio of 2  104
was determined for BPV virions, purified from warts in an
identical manner to our material (Roden et al., 1996). Ad-
ditionally, we evaluated the assay by processing RNA ob-
tained from BPHE-1 cells. These cells contain an estimated
50 copies of autonomously replicating genome (Zhang et
al., 1987). Material from approximately 10 BPHE-1 cells
yielded an obvious signal in the RT-PCR assay (data not
shown), indicating the utility of this method for sensitive
detection of BPV-infected cells.
This sensitive PCR assay was then used to determine if
BPV infection could be prevented with inhibitors of endo-
cytic pathways (see Table 1). Virions were bound to C127
cells for 60 min at 0°C; unbound virions were removed, and
infection was allowed to proceed by addition of 37°C me-
dium. For initial analysis, the inhibitor was present during
the entire infection, and two levels of input virions were
assayed to evaluate possible intermediate effects (Fig. 5).
The drugs that prevented infection were chlorpromazine,
bafilomycin A, NH4Cl, nocodazole, latrunculin B, and so-
dium azide. The first three inhibitors act on the clathrin-
endosomal pathway at various points (Bayer et al., 1998;
Clague et al., 1994; Subtil et al., 1994). Latrunculins prevent
polymerization of actin monomers (Spector et al., 1989).
Actin has been found to be nonessential for the internaliza-
tion of some clathrin-dependent ligands (Fujimoto et al.,
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2000; Salisbury et al., 1980; Sandvig and van Deurs, 1990).
Sodium azide causes the inhibition of oxidative phosphor-
ylation. Each of these inhibitors prevented infection at both
amounts of input virus. In contrast, treatment with filipin
and nystatin (Rothberg et al., 1992; Schnitzer et al, 1994),
which are two inhibitors of the caveolae-mediated uptake
pathway, had no effect on papillomavirus infection. How-
ever, infection with SV40, used as a positive control for this
pathway, was inhibited under these conditions (data not
shown). Additionally, the caveolar pathway bypasses the
acidified vesicular compartments so the effect of bafilomy-
cin A and NH4Cl on papillomavirus infection would be
inconsistent with caveolar uptake (Pelkmans et al., 2001).
We further analyzed a subset of the active inhibitors in a
time-course experiment to determine when each of the in-
hibitory drugs exerted its influence on infection. To deter-
mine at which point in the infectious entry pathway the
various inhibitors exerted their effects, inhibitors were
added 2, 4, 6, or 8 h after the initiation of the infection, or
for the entire infection as a positive control. The infection
was continued for a total of 12 h, at which point RNA was
prepared and analyzed for the presence of the BPV tran-
script (Fig. 6).
Treatment with chlorpromazine or bafilomycin A re-
sulted in a similar time course of inhibition. Each of these
drugs was inhibitory when added 2 h after infection, but did
not affect infection when added at the 4-h time point or
later, suggesting that they inhibit early aspects of infection.
This inference is also consistent with the known sites of
action of the drugs. Chlorpromazine blocks clathrin-depen-
dent endocytosis by causing the redistribution of AP-2
(Subtil et al., 1994; Wang et al., Anderson, 1993); bafilo-
mycin A is a vacuolar ATPase inhibitor (Lamaze et al.,
1997; Spector et al., 1989) that has also been shown to
affect transit of ligands from early endosomes into endoso-
mal carrier vesicles. Inhibition of infectivity at 2 h by these
agents is consistent with the above finding that the internal-
ization of VLPs is a relatively slow process. In contrast to
the above inhibitors, nocodazole is a microtubule depoly-
merizing agent that acts at a later point, by blocking the
transport from early to late endosomes in some cell types
(Bayer et al., 1998; Bomsel et al., 1990; Parton et al., 1991).
Consistent with a later site of inhibition, nocodazole pre-
vented infection when added through the initial 6 h of
infection. When it was added for the final 4 h of the infec-
tion, there was no effect. Additionally we found that treat-
ment with latrunculin B inhibited infection with a profile
indicating a relatively early action. While it has been de-
scribed that latrunculin B can prevent receptor-mediated
endocytosis at the stage of coated vesicle budding (Durr-
bach et al., 1996; Lamaze et al., 1997), other reports indicate
no role for actin in clathrin-dependent endocytosis (Fuji-
moto et al., 2000; Salisbury et al., Sandvig and van Deurs,
1990). This early role of actin could provide a valuable clue
as to the identity of the PV receptor.
Fig. 1. Colocalization of HPV-16 VLPs and BPV-1 virions. C127 cells
were coincubated with the two particle preparations and fixed after incu-
bation for 4 h (A–C) or 8 h (D–F). A and D show the distribution of HPV
16 L1 VLPs as detected with antibody V5 and goat anti-mouse IgG-FITC.
B and D show the pattern of BPV-1 virions, detected with 5B6-biotin and
a streptavidin Texas red conjugate. The merged images, C and F, illustrate
the extensive colocalization of VLPs and virions.
Fig. 2. BPV VLPs are slowly internalized. A shows the t1/2 of BPV VLPs
on the surface of C127 cells. Cells were incubated with VLPs at 0°C for
1 h. Excess VLPs were removed by extensive washing and cells were
incubated at 37°C for the described times. Shown are two independent
experiments. The plot for each experiment shows the average mean chan-
nel fluorescence, which was calculated from triplicate samples for each
time point. The value at the beginning of the 37°C incubation was con-
sidered to be 100%, and each subsequent value is based on that value. The
dissociation of VLPs from the cell surface was examined by ELISA (not
shown) and determined to insignificant (1% of bound). B shows an
example of the cell distribution of VLPs after 2 h incubation at 37°C.
Significant surface staining is evident and capping is obvious. Numerous
cytoplasmic vesicles are also becoming evident at this point.
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Fig. 3. Colocalization of VLPs with endocytic markers. VLPs were internalized in C127 cells for 2 h (A–C). 3 h (D–F), or 4 h (G–I). Cells were fixed and
double stained for endocytic markers and VLPs. Staining against BPV L1 is shown in B, E (antibody 5B6), and H (antibody no. 9). Anti-AP-2 staining, shown
in A, was detected with goat anti-mouse IgG-FITC. In this instance biotinylated 5B6 and streptavidin–Texas red were used to detect VLPs (B). The merge
of the two images is shown in C. Antitransferrin receptor staining is shown in D. This antiserum was detected with goat anti-rabbit IgG-FITC. 5B6 binding
was detected with goat anti-mouse IgG–Texas red. The merged image is shown in F. Localization of the Lamp-2 protein is shown in G. Binding was detected
with goat anti-rat IgG-FITC. Monoclonal antibody no. 9 was detected with goat anti-mouse IgG–Texas red. The merged image is in I. For all antibodies,
control images were evaluated to ensure nonoverlapping binding of secondary antibodies and specific detection for each excitation channel.
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Discussion
The early events of viral infection include virion attach-
ment to cellular receptors, penetration, and uncoating,
which is followed by viral gene transcription. As noted
above, nonenveloped DNA viruses generally enter cells via
one of two pathways, the clathrin-dependent endosomal
vesicular pathway or caveolae. In the current studies, we
have used three different approaches to identify the cellular
pathway used for early infection by PVs: morphology, sub-
cellular localization, and inhibition of viral transcription by
drugs with distinct sites of action. The evidence developed
by each approach supports the conclusion that PVs enter
cells via the clathrin-dependent pathway, rather than caveo-
lae, although with much slower kinetics than usually seen
with clathrin-dependent processes.
Morphologically, PVs were found in vesicles that are
characteristic of the clathrin-dependent pathway of internal-
ization. By subcellular localization, the PVs colocalized
with markers of this pathway. Biochemically, PV mRNA
synthesis, used as an index of viral entry and uncoating, was
inhibited by several drugs that interfere with the clathrin-
dependent pathway, but not by drugs that inhibit the caveo-
lae-dependent pathway.
Coated pits contain two major structural proteins, clath-
rin and the adaptor protein AP-2 (Pearse, 1976, 1978, 1989).
AP-2 complexes are localized to the plasma membrane-
derived coated pits. Adaptors play a critical role in the
attachment of clathrin to membranes and the recruitment of
membrane proteins that localize to clathrin-rich membrane
regions (Beck et al., 1992; Chang et al., 1993; Glickman et
al., 1989; Pearse, 1988; Pearse and Bretscher, 1981). The
observed colocalization of PV VLPs with AP-2 in cytoplas-
mic vesicles strongly implicates the clathrin-dependent
pathway in viral penetration. This conclusion was further
supported by colocalization, in a vesicular compartment, of
VLPs with the transferrin receptor, which is a marker of
early endosomes (Harding et al., 1983; Yamashiro and
Maxfield, 1984), a later compartment of the endocytic lin-
eage than that identified by AP-2. In these compartments,
the VLPs reacted with anti-L1 antibody 5B6, but not
strongly with antibody no. 9 (data not shown). Both anti-
bodies are neutralizing and recognize a conformational sur-
face epitope. However, no. 9 reacts with the top of the
capsomers and can interfere with virion binding to the cell
surface, while 5B6 reacts with the sides of the capsomers, at
a site just above intercapsomere cross-bridges, and does not
inhibit cell-surface binding (Booy et al., 1998; Roden et al.,
1994b). Therefore, one interpretation of the negative results
with antibody no. 9 is that when the virions or VLPs are
associated with the clathrin or early endosomal compart-
ments, their interaction with receptors is so extensive that
detectable no. 9 binding is prevented.
Although some viruses may escape from, or undergo
uncoating in, early endosomes (Bartlett et al., 2000; Bayer
et al., 1999; Greber et al., 1993), many continue to be
passaged, via endosomal carrier vesicles, to late endosomes
and then to lysosomes (Zeichhardt et al., 1985). Using the
Lamp-2 protein as a marker for late endosomes and lyso-
somes (Chen et al., 1985), we found that it colocalized with
BPV L1, at a later time than colocalization was observed
with the transferrin receptor. In contrast to the L1 antibody
Fig. 4. RT-PCR of BPV-infected C127 cells. (A) A BPV-specific transcript
is evident in infected cells after a 12-h infection. Purified BPV virions were
added to C127 cells at a dose of 500 ng/1  106 cells. Infection was
continued for the described times. RNA was extracted and RT-PCR reac-
tions for both BPV and -actin were performed. -Actin amplimers are
shown in the left half of the panel. BPV amplimers are shown on the right.
Lanes 1–6 indicate harvest at 6, 7, 8, 10, 12, and 14 h of infection,
respectively. The BPV specific band is evident at the 12- and 14-h time
points. (B) Titration of input virus. Different amounts of virions were used
to infect C127 monolayers. The BPV amplimers are shown. Lane 1 is the
uninfected control. Lane 8 shows the positive control of amplification from a
BPV-1cell line. Lanes 2–7 show the titration of virions from 1250, 500, 200,
80, 32, 13 ng/1 106 cells, respectively. The BPV amplimer is clearly visible
down to 80 ng/1  106 cells and weakly visible at 32 ng/1  106 cells.
Table 1
Panel of biochemical inhibitors that was examined for an effect on PV
infection
Inhibitor Site/Mode of Action PV
Infx
Bafilomycin A Inhibits vacuolar ATPase
Inhibits endosomal trafficking
No
Chlorpromazine Blocks entry of clathrin-coated
vesicles
No
Filipin Prevents caveolar-mediated
uptake
Yes
Latrunculin B Depolymerizes actin No
NH4Cl Raises endosomal pH No
Nocodazole Depolymerizes microtubules
Blocks trafficking into Les
No
Nystatin Prevents caveolar-mediated
uptake
Yes
Sodium azide Inhibits oxidative phosphorylation No
Note. Inhibitors were used at the following concentrations: bafilomycin
A, 100 nM; chlorpromazine, 25 M; filipin, 400 nM; latrunculin B, 63 m;
NH4Cl 20 mM; nocodazole, 10 m; nystatin, 27 M; sodium azide, 63
mM. The described mode of action of these inhibitors is listed. The
observed effect on BPV infection is also noted in the final column.
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results seen in association with AP-2 or the transferrin
receptor, L1 antibody no. 9 staining was positive in the
compartments associated with Lamp-2, while antibody 5B6
was largely negative. The positive reactivity to no. 9 sug-
gests that this epitope is no longer occupied by receptor
binding, a dissociation often seen with other viruses in the
Lamp-associated compartments. The negative reactivity to
5B6 suggests either that the viral particles have undergone
some relatively subtle conformational change or that they
have become partially disassembled. Substantial disassem-
bly seems unlikely, as it has been reported that when BPV
VLPs are dissociated to pentamers in vitro, they retain their
ability to bind 5B6 but lose their binding to no. 9, and
chimeric BPV VLPs have been identified that bind no. 9 but
not 5B6 (Slupetzky et al., 2001). The observation that some
no. 9 reactive material does not localize within the Lamp 
compartments may indicate the appearance of this epitope
coincides only with passage into the lysosome, leaving the
Lamp  late endosomes unreactive.
The above “bulk flow” analysis is useful in studying viral
entry. However, the particle-to-infectivity ratio raises the
possibility that nonproductive events could dominate results
obtained with this approach and thereby obscure visualiza-
tion of the authentic infective pathway. Therefore, we also
analyzed the production of an early viral mRNA transcript
as a measure of true infection and the ability of drugs that
inhibit various endocytic processes to interfere with produc-
tion of this transcription. By adding the inhibitors at various
times after the start of infection, it was also possible to infer
when during infection each drug was likely to be active.
We found that chlorpromazine, latrunculin B, and bafilo-
mycin A each inhibited accumulation of the viral transcript
if they were added 2 h after infection, but not 4 h after
infection, while nocodazole blocked even when added 4 h
after infection, although not when added at 6 h or later.
These results indicate PVs likely use the clathrin endocytic
pathway and that nocodazole probably inhibits a later step
than the other three drugs. A summary of these experiments
is illustrated in Fig. 7.
Latrunculins specifically affect the actin cytoskeleton by
sequestering actin monomers (Lamaze and Schmid, 1995;
Spector et al., 1989), and actin filaments have been shown
to be required at early steps in receptor-mediated endocy-
tosis in some cell systems (Durrbach et al., 1996; Lamaze et
al., 1997). However, despite the well-established require-
ment for actin in endocytosis in yeast (reviewed in Geli and
Riezman, 1998), in mammalian cells a connection between
the cytoskeleton and endocytic mechanisms has not been
clearly demonstrated (Fujimoto et al., 2000; Salisbury et al.,
1980; Sandvig and van Deurs, 1990). Actin has been shown
to be essential for the internalization of some heparan-
sulfated proteoglycans (HSPGs) (Fuki et al., 1997, 2000).
Cell-surface heparan sulfate is a requirement for PV infec-
Fig. 5. Pharmacalogic inhibition of BPV infection. C127 cells were in-
fected with either 500 ng/1  106 cells (leftmost lane in each pair) or 50
ng/1  106 cells (rightmost lane). Cells were either untreated (lanes A, D,
and H) or treated with various inhibitors throughout the entire infection.
Inhibitors are as follows: sodium azide, lanes B; filipin, lanes C; bafilo-
mycin A, lanes E; chlorpromazine, lanes F; latrunculin B, lanes G; no-
codazole, lanes I; NH4Cl, lanes J; nystatin, lanes K. The -actin amplimers
are shown in the gels in the right column and the corresponding BPV
amplimer is in the left column.
Fig. 6. Time course of pharmacologic inhibition. Virions were added to
C127 cells at 500 ng/1  106 cells. Infection was initiated by addition of
37°C medium. Inhibitors were present for either the entire infection or
added at 2-h intervals as indicated above the lanes. Infection was continued
for 12 h total whereupon the cells were processed for RNA extraction. The
-actin amplimers are shown on the right-hand side of the gel and the BPV
amplimers are on the left. A, Treatment with chlorpromazine; B, with
latrunculin B; C, with bafilomycin A; D, with nocodazole.
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tion (Giroglou et al, 2001). This could indicate a link be-
tween the poorly defined HSPG internalization pathway and
the well-defined clathrin pathway. Our future studies will
explore this possibility.
Chlorpromazine specifically blocks clathrin-mediated
endocytosis by causing a redistribution of AP-2 away from
clathrin-containing pits (Subtil et al., 1994; Wang et al.,
1993). The ability of chlorpromazine and latrunculin B to
inhibit early during infection suggests that early events in
PV infection are mediated by a clathrin-dependent process
and require an intact actin cytoskeleton. The actin require-
ment is also consistent with the results of a previous study
of PV VLP internalization (Zhou et al., 1995).
Bafilomycin A has been shown to affect early endosomal
trafficking (Bayer et al., 1998; Clague et al., 1994), in
addition to its well-established inhibition of vacuolar
ATPases (Bowman et al., 1988; Yoshimori et al., 1991).
Therefore, the inhibition with bafilomycin A can be inter-
preted as implying that PV uncoating depends on exposure
to low pH and/or that productive uncoating occurs in late
endosomal compartments. The latter possibility must be
seriously considered, since nocodazole prevents the traf-
ficking of early endosomes to late endosomes by depoly-
merizing microtubules. However, infection was found to be
inhibited by other lysosomotropic drugs, NH4Cl (Fig. 5) and
chloroquine (data not shown), implying a likely requirement
for low pH. It should also be noted that nocodazole inter-
fered with infection even if added at a time when infection
was resistant to treatment with chlorpromazine, latrunculin
B, or bafilomycin A. As the infective process is beyond the
early-to-late endosome transition by then, this result implies
that microtubule function may also be required at a rela-
tively late step, possibly the transition from the vesicular
compartments to the nucleus. An association between pap-
illomavirus L1 and microtubules has recently been de-
scribed (Liu et al., 2001).
The inhibitor profiles and internalization kinetics indi-
cate that PV infection occurs much more slowly than con-
ventional endocytosis, where typical ligand–receptor com-
plexes transit to peripheral early endosomes in fewer than
10 min (Hanover et al., 1984, 1985; Schmid et al., 1988).
Our observations suggest that virions do not exit early
endosomes within the first 2 h of internalization, with their
transit into late endosomes occurring by approximately 4 h,
and their exit from late endosomes in the 6- to 8-h window.
We do not have a clear explanation for this slow rate. JC
virus uses the clathrin-dependent pathway, but it enters cells
with much faster kinetics (Pho et al., 2000). By contrast, the
long period at the cell surface prior to entry is also seen with
SV40 (Pelkmans et al., 2001). However, SV40 internaliza-
tion is well established to occur via caveolar endocytosis
(Anderson et al., 1996; Stang et al., 1997).
Given that the polyomaviruses SV40 and JC enter cells
via distinct pathways, it is theoretically possible that not all
PVs follow the clathrin-dependent pathway. However, pre-
viously published evidence indicates that HPV 16 VLPs can
compete with BPV for cell-surface binding (Roden et al.,
1994a), and here we have found that HPV 16 VLPs, BPV
VLPs, and BPV virions enter cells with the same kinetics
and via the same compartments. Since HPV 16 and BPV are
evolutionarily divergent (Chan et al., 1995; Myers et al.,
1996), it therefore seems likely that all PVs enter cells by
the same process.
The kinetics, subcellular localization, and biochemical
inhibition profiles of PV do not completely align with any
defined internalization schemes. The clathrin-dependent
pathway utilized by interleukin-2 receptors does intersect
with the endosomal compartment. However, it exhibits
rapid kinetics and would not show colocalization with
preendosomal markers such as AP-2 (Lamaze et al., 2001).
Several bacterial toxins enter cells via a clathrin-indepen-
dent, noncaveolar pathway. However, these toxins, cholera
toxin, shiga toxin, and verotoxin, do not intersect with the
later endosomal compartments and are not affected by
bafilomycin, nocodazole, and NH4Cl. They are directly
transported from early endosomes into the Golgi apparatus
(Falnes and Sandvig, 2000; Mallard et al., 1998; Nichols
and Lippincott-Schwartz, 2001; Orlandi and Fishman,
1998). Therefore, although the kinetics are atypical for
ligands internalized via clathrin-dependent pathways, the
preponderance of evidence, including colocalization of PV
with markers of this pathway and inhibition with biochem-
ical agents consistent with clathrin-mediated uptake, sup-
ports the conclusion that PV infection occurs via this path-
way. The explanation for the slow rate of internalization and
actin dependence may lie in the identification of the PV
receptor(s). Although the definitive receptor remains unde-
fined, a dependence upon the presence of cell-surface hepa-
ran sulfate has been well established. HSPGs have been
shown to be internalized slowly and this pathway of uptake
Fig. 7. PVs enter the cell via a clathrin-dependent pathway. This illustration
shows the well-established endocytic pathway via clathrin-coated vesicles.
The points at which the various inhibitors act in the internalization scheme
are shown. The approximate time that it takes PVs to reach each compart-
ment of the pathway is indicated on the far right. This determination was
based on microscopic colocalization with markers specific for the com-
partments and by inhibition of infection with the designated compounds.
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is inhibited by biochemical agents that affect actin polymer-
ization (Fuki et al., 1997, 2000). The pathway utilized by
most HSPGs has not been elucidated. Perhaps our observa-
tions indicate that some ligands internalized by association
with HSPGs enter into a classical endocytic route.
Materials and methods
Reagents
C127 cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with antibiotics and 10% fetal calf
serum. Antibodies 5B6 and no. 9, which recognize the
native BPV L1 protein, and antibody V5, which recognizes
native HPV16 L1, have all been described previously (Booy
et al., 1998; Roden et al., 1994b). For some experiments
biotinylated 5B6 was used. This conjugate was prepared
using a succinimidyl ester of biotin according to standard
techniques. Mouse monoclonal antibody recognizing AP-2
was purchased from Affinity Bioreagents. Rabbit polyclonal
antiserum raised to the transferrin receptor was purchased
from Santa Cruz Biotechnology. Rat monoclonal antibody
ABL-93, against Lamp-2, was provided by Dr. Jonathan
Yewdell. HPV L1 and BPV-1 L1/L2 VLPs were prepared
from a baculovirus expression system in SF-9 cells as pre-
viously described (Kirnbauer et al., 1993). BPV-1 virions
were purified from bovine warts according to previously
described methods (Roden et al., 1996).
Infection with BPV-1 virions
Unless otherwise stated, purified virions were added to
cultures of adherent cultures of C127 cells at a dose of 500
ng/106 cells. Virions were bound to cells in PBS, 2% FBS for
60 min on ice. Unbound virions were removed by three PBS
washes. Infection was initiated by addition of 37°C medium
and continued for 12 h, whereupon the cells were trypsinized,
washed twice with PBS, and processed for RNA extraction.
For inhibitor studies, the 37°C medium containing the speci-
fied drug was added to the infection at the indicated times.
Inhibitors were used at the following concentrations: bafilo-
mycin A, 100 nM (Alexis Biochemical); chlorpromazine, 25
M (Calbiochem); filipin, 400 nM (Sigma); latrunculin B, 63
m (Molecular Probes); NH4Cl, 20 mM (Sigma); nocodazole,
10 m (Calbiochem); nystatin, 27 M (Sigma), sodium azide,
63 mM (Sigma). The sodium azide treated cells were incu-
bated in glucose-free medium. All other incubations were per-
formed in the standard growth medium.
RT-PCR and PCR
PCR primers to detect BPV transcripts are as follows:
forward outside primer; 5 gcgcgcaccagctcgacgtccctgct 3
(BPV nt 761–780); reverse outside primer; 5 cacacagctct-
gatgggaccgcaggc 3 (BPV nt 3350–3331); forward inside
primer; 5 gcgcgcactcagatttagacctcttg 3 (BPV nt 801–820);
reverse inside primer: 5 cacacaggctgggctggctcggcttc 3
(BPV nt 3305–3286). PCR primers to detect -actin tran-
scripts are as follows: forward outside: 5 gcgcgcgtcatggt-
gggcatgggcca 3 (actin nt 145–165); reverse outside: 5
cacacaccggccagccaggtccagac 3 (actin nt 587–567); forward
inside; 5 gcgcgctgggacgacatggagaagatc 3 (actin nt 277–
297); reverse inside; 5 cacacaagagtcgatgacaatgccagt 3 (ac-
tin nt 484–504). RNA was prepared using the kit RNAque-
ous (Ambion) according to the manufacturer’s directions
with the additional step of DNase 1 digestion (30 U/ml for
30 min at 37°C). One microgram of RNA was used as the
template for RT-PCR using an RT-PCR kit (Roche) accord-
ing to the manufacturer’s directions. One microliter, equiv-
alent to 2% of the completed reaction, was used as a tem-
plate for a second round of PCR. The products of the second
reaction were analyzed by agarose gel electrophoresis.
Immunofluorescent staining
For microscopy C127 cells were seeded onto acid-
washed no. 01 coverslips in 24-well plates at a density of
105 cells/well and cultured overnight. VLPs were attached
to cells at a concentration of 5 g/ml in PBS, 2% FBS for
60 min on ice. Unbound VLPs were removed by washing
and cells were incubated in complete medium at 37°C for
the specified time. Cells were fixed and processed for mi-
croscopy as previously described (Day et al., 1998). For
double immunofluorescent staining involving primary anti-
bodies from different host species, the antibodies were in-
cubated in unison. For double staining using 5B6 and a
second mouse antibody, biotinylated 5B6 was used and
detected with Texas red conjugated streptavidin after com-
pletion of the staining procedure for the other antibody.
Fluorescence was examined with a Bio-Rad MRC 1024
laser scanning confocal system attached to a Zeiss Axioplan
microscope. All the images were acquired with a Zeiss 63
N.A. 1.4 Planapo objective. The use of control coverslips
established that fluorescence in the green and red channels
was not overlapping and that antibody binding was specific
for the intended antigen. The images were collaged and
subjected to scale adjustment with Adobe Photoshop soft-
ware. For flow cytometric analysis VLPs, 5 g/ml in PBS,
2% FBS, were bound to 1  106 C127 cells in suspension
with rocking at 4°C for 60 min. Unbound VLPs were
removed by extensive washing with PBS. Prewarmed 37°C
media was added to the cells and time points were taken at
the indicated times. Cells were stained with 5B6 and FITC-
conjugated donkey anti-mouse IgG in PBS, 2% FBS, 0.1%
NaN3. The logarithmic fluorescent intensity was analyzed
on a FACSCalibur flow cytometer (Becton–Dickinson).
ELISA
During the flow cytometric analysis experiment de-
scribed above, the supernatants from each time course were
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reserved to determine the off rate and quantify the amount
of VLPs that dissociate from the cell surface prior to inter-
nalization. The reactivity of 5B6 against the BPV-1 VLP
preparation was determined as previously described (Wider-
off et al., 1995). Two hundred microliters of the supernatant
(400 _l total volume) was bound to the plate (Immunolon
2HB, Dynex Technologies). The 5B6 ascites were used at a
dilution of 5  104. The detection of VLPs at this dilution
of antibody was determined to be sensitive down to 5 ng of
antigen.
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